Search research articles
Contact Us
Filters
Showing results (41-50 of 104) with videos related to
Page
of 11
Sort By:
Cancer Chemotherapy and Pharmacology
|
February 14, 2008
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
Geoffrey Y Ku, David H Ilson, Lawrence H Schwartz, et al.
Annals of Surgical Oncology
|
March 12, 2021
Comparison of Long- and Short-term Outcomes in 845 Open and Minimally Invasive Gastrectomies for Gastric Cancer in the United States
Masaya Nakauchi, Elvira Vos, Yelena Y Janjigian, et al.
Cancers
|
June 24, 2022
Can <sup>18</sup>F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?
Vetri Sudar Jayaprakasam, Peter Gibbs, Natalie Gangai, et al.
Journal of Gastrointestinal Oncology
|
April 30, 2019
Maximizing response: a case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma
Megan Greally, Rajiv Agarwal, Imane El Dika, et al.
Cancer
|
October 13, 2011
Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer
David H Ilson, Bruce D Minsky, Geoffrey Y Ku, et al.
Journal of Thoracic Disease
|
June 11, 2019
Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases
Yongshun Chen, Xinyu Cheng, Haixia Song, et al.
Plos One
|
August 15, 2015
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer
Yelena Y Janjigian, Efsevia Vakiani, Geoffrey Y Ku, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2014
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
Jianda Yuan, Geoffrey Y Ku, Matthew Adamow, et al.
BMC Cancer
|
June 28, 2018
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Danielle C Glassman, Randze L Palmaira, Christina M Covington, et al.
Cancer
|
May 7, 2016
Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma
Geoffrey Y Ku, Anuja Kriplani, Yelena Y Janjigian, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 104) with videos related to
Sort By:
Page
of 11
Cancer Chemotherapy and Pharmacology
|
February 14, 2008
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
Geoffrey Y Ku, David H Ilson, Lawrence H Schwartz, et al.
Annals of Surgical Oncology
|
March 12, 2021
Comparison of Long- and Short-term Outcomes in 845 Open and Minimally Invasive Gastrectomies for Gastric Cancer in the United States
Masaya Nakauchi, Elvira Vos, Yelena Y Janjigian, et al.
Cancers
|
June 24, 2022
Can <sup>18</sup>F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?
Vetri Sudar Jayaprakasam, Peter Gibbs, Natalie Gangai, et al.
Journal of Gastrointestinal Oncology
|
April 30, 2019
Maximizing response: a case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma
Megan Greally, Rajiv Agarwal, Imane El Dika, et al.
Cancer
|
October 13, 2011
Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer
David H Ilson, Bruce D Minsky, Geoffrey Y Ku, et al.
Journal of Thoracic Disease
|
June 11, 2019
Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases
Yongshun Chen, Xinyu Cheng, Haixia Song, et al.
Plos One
|
August 15, 2015
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer
Yelena Y Janjigian, Efsevia Vakiani, Geoffrey Y Ku, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2014
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
Jianda Yuan, Geoffrey Y Ku, Matthew Adamow, et al.
BMC Cancer
|
June 28, 2018
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Danielle C Glassman, Randze L Palmaira, Christina M Covington, et al.
Cancer
|
May 7, 2016
Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma
Geoffrey Y Ku, Anuja Kriplani, Yelena Y Janjigian, et al.
Page
of 11